comparemela.com

Latest Breaking News On - Tela bio - Page 1 : comparemela.com

TELA Bio Full Year 2023 Earnings: US$2.04 loss per share (vs US$2.72 loss in FY 2022)

TELA Bio ( NASDAQ:TELA ) Full Year 2023 Results Key Financial Results Revenue: US$58.5m (up 41% from FY 2022). Net.

Medical-equipment
Tela-bio
Medical-equipment
Net-loss

With 54% institutional ownership, TELA Bio, Inc. (NASDAQ:TELA) is a favorite amongst the big guns

Australian Broker Call *Extra* Edition - Feb 07, 2024

Insider Buying: TELA Bio, Inc. (NASDAQ:TELA) Insider Buys 2,600 Shares of Stock

TELA Bio, Inc. (NASDAQ:TELA – Get Free Report) insider Gregory A. Firestone bought 2,600 shares of the business’s stock in a transaction on Tuesday, December 5th. The stock was bought at an average price of $5.65 per share, with a total value of $14,690.00. Following the purchase, the insider now owns 35,511 shares in the […]

Gregorya-firestone
Townsquare-capital
Tela-bio-inc
Rock-asset-management
Nasdaq
Securities-exchange-commission
Sectoral-asset-management-inc
Bio-inc
Stonepine-capital-management
Sbio-company-profile
Get-free-report

Stonepine Capital Management LLC Takes $4.89 Million Position in TELA Bio, Inc. (NASDAQ:TELA)

Stonepine Capital Management LLC purchased a new stake in shares of TELA Bio, Inc. (NASDAQ:TELA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 482,619 shares of the company’s stock, valued at approximately $4,889,000. TELA Bio accounts for […]

United-states
New-york
American
Antony-koblish
Securities-exchange-commission
Sbio-company-profile
Nasdaq
Bio-inc
Barclays-plc
Stonepine-capital-management
American-international-group-inc
Jacob-asset-management-of-new-york

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.